Alteration of CFTR transmembrane span integration by disease-causing mutations

Anna E Patrick1, Andrey L Karamyshev, Linda Millen

  • 1Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX 75235, USA.

Insights

Cystic fibrosis mutations in CFTR protein spans cause misfolding and ER accumulation. Different mutations, like G85E and G91R, lead to distinct molecular disruptions, explaining CF pathology.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Missense mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein are a primary cause of cystic fibrosis (CF).
  • Many CF-causing CFTR mutations lead to protein misfolding and accumulation in the endoplasmic reticulum (ER), preventing proper protein maturation and function.
  • Specific mutations within CFTR's transmembrane (TM) domains are implicated in altered protein integration, but their precise effects remain unclear.

Purpose of the Study:

  • To experimentally determine the ER luminal integration profiles of CFTR's first two transmembrane spans (TM1 and TM2).
  • To investigate the impact of two CF-associated missense mutations, G85E and G91R, located in TM1, on CFTR's integration and conformation within the ER.

Main Methods:

  • Utilized the ER glycosylation machinery to map the integration of CFTR TM1 and TM2 within the ER membrane.
  • Assessed the effects of G85E and G91R mutations on CFTR's conformational stability and ER integration profiles.

Main Results:

  • The G85E mutation destabilizes the TM1 conformation, leading to temperature-insensitive ER accumulation of immature CFTR.
  • The G91R mutation alters the TM1 ER integration profile, causing temperature-dependent misfolding due to the introduction of a charged residue.
  • CF-causing mutations with similar predicted structural effects can induce disparate molecular perturbations.

Conclusions:

  • CFTR TM span integration and conformational stability are critical for proper protein folding and function.
  • Specific missense mutations in CFTR TM domains lead to distinct molecular defects, including altered ER integration and stability.
  • Understanding these mutation-specific mechanisms is crucial for developing targeted therapies for cystic fibrosis.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Mutations01:39

Mutations

Overview
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...